Healthcare -
Biotechnology - NASDAQ - US
$ 5.48
1.48 %
$ 326 M
Market Cap
-7.31
P/E
ALDX - COST OF REVENUE
Cost of Revenue ALDX - Aldeyra Therapeutics, Inc.
263 K
LAST VALUE
-0.27%
2 YEAR CAGR
29.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR